Include the workflow objective, owner, affected parties, data and source map, authority contract, provider dependencies, implemented controls, test environment, cases, results, findings, remediation, operating observations, cost record, and final release decision. Link to controlled artifacts rather than copying sensitive material into a public summary. Identify evidence dates and material-change triggers so the packet does not remain apparently current after its basis changes.
Add claim-approved wording and a do-not-claim list. The summary might accurately describe that specified controls were tested in a bounded environment while prohibiting statements about certification, complete compliance, universal security, guaranteed outcomes, or every production deployment. Legal, security, privacy, compliance, finance, and customer-evidence owners review the sections within their authority. Unresolved items remain visible to the buyer.
A concise buyer-facing index can identify which artifacts are public, available under diligence, restricted to designated reviewers, or unavailable. That status prevents a salesperson from promising evidence that cannot be shared and helps the buyer plan its review. Restrictions should have a real confidentiality or security basis; they should not be used to conceal a gap while implying that comprehensive proof exists somewhere else.
The packet should preserve provenance when a summary is regenerated. A changed date or polished narrative must not detach the conclusion from the test, finding, or approval that supports it. Stable references, versioned wording, and reviewer identity let later teams determine whether they are looking at the same evidence or a new interpretation that requires another approval.